Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4

Rhea-AI Summary

Avadel Pharmaceuticals plc (AVDL) schedules conference call to discuss financial results for Q4 and full year 2023, along with a corporate update.

DUBLIN, Ireland, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 7:30 a.m. ET on Monday, March 4, 2024, to provide a corporate update and discuss the Company's financial results for the fourth quarter and full year ended December 31, 2023.

Avadel plans to issue its Annual Report on Form 10-K for the year ended December 31, 2023, on Thursday, February 29.

A live audio webcast of the call can be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event. Participants may register for the conference call here and are advised to do so at least 10 minutes prior to joining the call.

About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Mogerley
Stern Investor Relations, Inc.
Courtney.Mogerley@sternir.com
(212) 698-8687

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162

FAQ

When will Avadel Pharmaceuticals plc host a conference call to discuss financial results for the fourth quarter and full year 2023?

Avadel Pharmaceuticals plc will host a conference call on Monday, March 4, 2024, at 7:30 a.m. ET.

Where can the live audio webcast of the call be accessed?

The live audio webcast of the call can be accessed by visiting the investor relations section of Avadel Pharmaceuticals plc's website, www.avadel.com.

When will Avadel Pharmaceuticals plc issue its Annual Report on Form 10-K for the year ended December 31, 2023?

Avadel Pharmaceuticals plc plans to issue its Annual Report on Form 10-K on Thursday, February 29, 2024.

How long will the replay of the webcast be available on Avadel Pharmaceuticals plc's website?

The replay of the webcast will be archived on Avadel Pharmaceuticals plc's website for 90 days following the event.

How far in advance should participants register for the conference call?

Participants are advised to register for the conference call at least 10 minutes prior to joining the call.